Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Pfizer claims new cannabinoid CB1 receptor antagonists for obesity

Feb. 17, 2005

Merck Frosst claims novel inhibitors of leukotriene biosynthesis

Feb. 16, 2005

New DPP-IV inhibitors for the treatment of NIDDM reported by Fujisawa

Feb. 16, 2005

New 5-HT receptor modulators claimed by Suven Life Sciences

Feb. 16, 2005

Genelabs Technologies presents novel antiviral agents

Feb. 16, 2005

Thrombopoietin receptor (TPOR) activators disclosed by Nissan Chemical

Feb. 16, 2005

Antibacterial prodrugs of 6-beta-hydroxymethylpenicillanic acid sulfone claimed in Pfizer patent

Feb. 16, 2005

New humanized anti-beta amyloid peptide monoclonal antibodies jointly reported by Neuralab and Wyeth

Feb. 15, 2005

Novel NMDA/NR2B antagonists discovered at Merck

Feb. 15, 2005

FibroGen claims new hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors

Feb. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...